Category Archives: BioUtah News
Nomi Health Acquires Everyone Health, Sano Surgery
As Americans continue to pay more for needed medical treatments and with care costs outpacing the rate of inflation, Nomi Health — the direct healthcare company making it easier than ever to access the highest quality affordable care across the U.S.— today announced two acquisitions to bolster its support of buyers of care and their […]
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
Co-Diagnostics announced that it has shipped testing reagents for monkeypox virus currently exhibiting a multi-country outbreak to one of its international distributors.
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
Biomerics announced the acquisition of Dependable Plastics and creation of a new division — Biomerics Interventional Medical Plastics (IMP) Division.
Senate Democrats Renew Plan for Drug Price Controls
Senate Democrats have renewed a push for drug pricing reforms, releasing on Wednesday proposed legislation along with a bill summary.
BD Names Rishi Grover as Chief Integrated Supply Chain Officer
FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022. In this role, Grover will have global responsibility for the […]
Spectrum Wins Two Science & Technology Best of State Awards
Spectrum Solutions, LLC today announced it has been awarded two Utah Best of State Science & Technology Awards for Medical Innovation and Laboratory Equipment and Supplies.
$10k Women’s Seed Grant Announced at Inaugural BioHive Women’s Event
On June 24, BioHive held their inaugural Women’s event sponsored by BD, BioMerieux, e4H Architects, Health Catalyst, Known Medicine, MarshMcLennan, Recursion, Seek Labs and JLL Realty. With 180 registrants from 54 companies, attendees packed over 200 STEM Kits in partnership with Utah STEM Action Center for elementary and middle school students, listened to a panel […]
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter ended March 31, 2022. Recent Highlights (including […]
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration
Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s network
U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform
Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.
One Utah Health Collaborative and Utah’s BioHive Community
Governor Cox has invited Utah’s life sciences industry to engage in a bold initiative called the “One Utah Health Collaborative.” Cox understands the importance of our industry to the healthcare system and it’s appropriate that we be at the table. Below we provide more detailed information about the initiative and opportunities to participate. Background Last […]
Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research
Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance research intended to improve outcomes for cancer patients. Intermountain Healthcare is leveraging Tempus’ solid tumor/normal genomic test, xT, to generate whole transcriptomic data on existing […]
